Hi Pivalde. Nice post. What do you make of the higher 75mg dose scoring lower than the 50mg dose. When you consider that the strong chelators on the market all failed to help in MSA due to iron attraction being too strong, it is not so surprising that the moderate dose here looks like the right dose in early stage patients. When the FDA is considering any approval, they assemble a panel of the foremost experts in the country to review all the evidence. The speakers include patients advocates. along with the company representatives. Members of the advisory panel include medical doctors, statisticians, pharmacologists etc IMO Ath is at a big advantage having a man like Stamler who has successfully come through the process before on multiple occasions.
ATH Price at posting:
0.8¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)